tiprankstipranks
Trending News
More News >

Daniel Tillett Insider Profile

25 Followers
Daniel Tillett, Chief Executive Officer & Managing Director at Race Oncology Ltd., holds 17.76M shares in Race Oncology Ltd. (Ticker: AU:RAC), holds 44.19M shares in Simble Solutions Ltd. (Ticker: AU:SIS), holds 62.00M shares in Tryptamine Therapeutics (Ticker: AU:ENP). Most recently, Daniel Tillett Bought ― shares of Race Oncology Ltd. on Nov 28, 2025 for an estimated value of AU$58.74K.
tipranks
Daniel  Tillett

Daniel Tillett
Race Oncology Ltd. (RAC)
Chief Executive Officer & Managing Director

Ranked #182 out of 105,077 Corporate Insiders

Profitable Transactions

29%
4 out of 14 Profitable Transactions

Average Return

+133.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$49M
95.73%
4.27%
0.00%
A breakdown of Daniel Tillett's holdings

Insider Roles

Race Oncology Ltd.
(RAC)
Chief Executive Officer & Managing Director
Tryptamine Therapeutics
(ENP)
Director
Simble Solutions Ltd.
(SIS)
Director
Roles that Daniel Tillett holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Daniel Tillett

Daniel Tillett's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Race Oncology Ltd.
Nov 28, 2025
Chief Executive Officer & Managing Director
Informative Buy
58.74K
AU$47.24M
Simble Solutions Ltd.
Mar 28, 2023
Director
Informative Buy
50.00K
Tryptamine Therapeutics
Director
AU$2.11M
List of latest transactions for each holding click on a transaction to see Daniel Tillett's performance on stock

Daniel Tillett insider profile FAQ

What is the percentage of profitable transactions made by Daniel Tillett?
The percentage of profitable transactions made by Daniel Tillett is 29%.
    What is the average return per transaction made by Daniel Tillett?
    The average return per transaction made by Daniel Tillett is 133.20%.
      What stocks does Daniel Tillett hold?
      Daniel Tillett holds: AU:RAC, AU:SIS, AU:ENP stocks.
        What was Daniel Tillett’s latest transaction?
        Daniel Tillett latest transaction was an Informative Buy of AU$58.74K.
          What was Daniel Tillett's most profitable transaction?
          Daniel Tillett’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Daniel Tillett's role in Race Oncology Ltd.?
            Daniel Tillett's role in Race Oncology Ltd. is Chief Executive Officer & Managing Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.